EMERADE

This brand name is authorized in Austria, Canada, Finland, France, Ireland, Netherlands, Spain, UK.

Active ingredients

The drug EMERADE contains one active pharmaceutical ingredient (API):

1	Epinephrine UNII 30Q7KI53AK - EPINEPHRINE BITARTRATE
	Epinephrine is a direct acting sympathomimetic agent, which exerts effects on both α and β adrenoceptors. It has more pronounced effects on β than on α adrenoceptors, although α effects prevail at high doses. The effects of adrenaline include increased rate and force of cardiac contraction, cutaneous vasoconstriction and broncho-dilatation.
	Read more about Epinephrine

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
EMERADE Solution for injection in a pre-filled pen	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C01CA24	Epinephrine	C Cardiovascular system → C01 Cardiac therapy → C01C Cardiac stimulants excl. cardiac glycosides → C01CA Adrenergic and dopaminergic agents
Discover more medicines within C01CA24

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
CA	Health Products and Food Branch	02458446, 02458454
ES	Centro de información online de medicamentos de la AEMPS	80146, 80147, 80149
FI	Lääkealan turvallisuus- ja kehittämiskeskus	041216, 090156, 134539, 185060, 528027, 535938
FR	Base de données publique des médicaments	67644301, 68944561, 69549631
GB	Medicines & Healthcare Products Regulatory Agency	234155, 234159, 234202
IE	Health Products Regulatory Authority	23614, 23615, 30214
NL	Z-Index G-Standaard, PRK	145262, 145440, 145459